Sue Desmond-Hellmann, the former CEO of the Bill and Melinda Gates Foundation who serves as a director at Pfizer, shared key lessons about board dynamics and leadership in this interview with me and my colleague, David Reimer, the CEO of Merryck &...
Clinical trial pauses are not uncommon, but they are generating outsized attention in the race to test Covid-19 vaccines.
Sue Desmond-Hellmann@MattHerper report: J&J Covid-19 vaccine study paused due to illness. Nature of the illness is not yet public. This is a 60,000 patient study started 9/23/20. The AstraZeneca/Oxford vaccine trial remains paused in the US.
During the current COVID-19 pandemic, the concept of herd immunity has become a topic of much debate. This Comment examines the factors that determine it, discusses how far we have come and considers what it will take to reach herd immunity safely.
Sue Desmond-HellmannDid you watch Senator Paul and Dr. Fauci mix it up on #COVID today? Recommend: COVID-19 herd immunity: where are we? | Nature Reviews Immunology
Named one of the best books of the year by NPR, Fortune, Bloomberg, Sunday Times
A New York Times Book Review Editor’s Choice
“If you want to understand modern-day Silicon Valley, you need to read this book.” —John Carreyrou, New York Times...
I suppose that I'm going to have to say something about yesterday's convalescent plasma announcement. First, the medical aspects: in my view, for what that's worth, convalescent plasma is likely to be at least somewhat helpful to hospitalized...